This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Oct 10;26(29):4851-2; author reply 4852-3.

doi: 10.1200/JCO.2008.18.2857. Epub 2008 Sep 8.

Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia

Asher A Chanan-Khan, Amy Whitworth, Naveen Bangia, Carl W Porter, Kelvin Lee

PMID: 18779599
DOI: 10.1200/JCO.2008.18.2857

Comment

Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia

Asher A Chanan-Khan et al. J Clin Oncol. 2008.

. 2008 Oct 10;26(29):4851-2; author reply 4852-3.

doi: 10.1200/JCO.2008.18.2857. Epub 2008 Sep 8.

Authors

Asher A Chanan-Khan, Amy Whitworth, Naveen Bangia, Carl W Porter, Kelvin Lee

PMID: 18779599
DOI: 10.1200/JCO.2008.18.2857

No abstract available

PubMed Disclaimer

Comment on

Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia.
Andritsos LA, Johnson AJ, Lozanski G, Blum W, Kefauver C, Awan F, Smith LL, Lapalombella R, May SE, Raymond CA, Wang DS, Knight RD, Ruppert AS, Lehman A, Jarjoura D, Chen CS, Byrd JC. Andritsos LA, et al. J Clin Oncol. 2008 May 20;26(15):2519-25. doi: 10.1200/JCO.2007.13.9709. Epub 2008 Apr 21. J Clin Oncol. 2008. PMID: 18427150 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.